Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3651
KT
KT
$8.83B
| $977K | ﹤0.01% |
84,171
-315,217
| -79% | -$3.59M |
|
3652
PUT
ResMed
RMD
$32.5B
| $976K | ﹤0.01% |
6,300
+2,500
| +66% | +$360K |
|
3653
iShares Semiconductor ETF
SOXX
$48.1B
| $976K | ﹤0.01% |
11,667
-233,283
| -95% | -$17.9M |
|
3654
CALL
Ally Financial
ALLY
$13.4B
| $975K | ﹤0.01% |
31,900
-2,500
| -7% | -$78K |
|
3655
CALL
Invesco DB US Dollar Index Bullish Fund
UUP
$424M
| $974K | ﹤0.01% |
37,500
-107,500
| -74% | -$2.87M |
|
3656
CALL
GameStop
GME
$8.61B
| $970K | ﹤0.01% |
638,000
+360,400
| +130% | +$529K |
|
3657
PUT
H&R Block
HRB
$5.81B
| $970K | ﹤0.01% |
41,300
+27,300
| +195% | +$655K |
|
3658
Monarch Casino & Resort
MCRI
$2.19B
| $967K | ﹤0.01% |
19,923
+1,984
| +11% | +$88.2K |
|
3659
CALL
STMicroelectronics
STM
$47.9B
| $966K | ﹤0.01% |
35,900
-411,200
| -92% | -$9.73M |
|
3660
CALL
Exelixis
EXEL
$13.1B
| $959K | ﹤0.01% |
54,400
-42,400
| -44% | -$719K |
|
|
PEI
3661
DELISTED
Pennsylvania Real Estate Investment Trust
PEI
| $959K | ﹤0.01% |
11,990
+770
| +7% | +$64.1K |
|
3662
PUT
iShares MSCI United Kingdom ETF
EWU
$4.14B
| $958K | ﹤0.01% |
28,100
+21,000
| +296% | +$683K |
|
3663
Invesco DB Commodity Index Tracking Fund
DBC
$1.66B
| $957K | ﹤0.01% |
59,995
+4,285
| +8% | +$66.5K |
|
3664
PUT
Neurocrine Biosciences
NBIX
$16.3B
| $957K | ﹤0.01% |
8,900
-31,700
| -78% | -$3.32M |
|
|
CWEN.A
3665
DELISTED
Clearway Energy Class A
CWEN.A
| $956K | ﹤0.01% |
50,009
+1,242
| +3% | +$22.9K |
|
3666
PUT
Vanguard FTSE Europe ETF
VGK
$31.1B
| $955K | ﹤0.01% |
16,300
+3,400
| +26% | +$190K |
|
3667
Gaotu Techedu
GOTU
$451M
| $953K | ﹤0.01% |
43,611
+38,861
| +818% | +$661K |
|
|
COOP
3668
DELISTED
Mr. Cooper
COOP
| $952K | ﹤0.01% |
76,128
+38,606
| +103% | +$474K |
|
3669
Western Alliance Bancorporation
WAL
$8.93B
| $952K | ﹤0.01% |
16,706
-119,829
| -88% | -$6.12M |
|
|
PENG
3670
Penguin Solutions Inc
PENG
$2.92B
| $952K | ﹤0.01% |
50,172
+10,054
| +25% | +$156K |
|
3671
CareDx
CDNA
$2.35B
| $951K | ﹤0.01% |
44,094
+21,927
| +99% | +$503K |
|
3672
Century Casinos
CNTY
$33.5M
| $951K | ﹤0.01% |
120,115
+40,890
| +52% | +$319K |
|
3673
MGP Ingredients
MGPI
$381M
| $950K | ﹤0.01% |
19,604
+6,127
| +45% | +$287K |
|
3674
PUT
Zions Bancorporation
ZION
$10.3B
| $950K | ﹤0.01% |
18,300
-700
| -4% | -$34K |
|
3675
Invesco S&P 500 Equal Weight ETF
RSP
$98.7B
| $949K | ﹤0.01% |
8,207
-4,400
| -35% | -$489K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.